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ABSTRACT 14 
Recently, there is an emergence of endocrine-disrupting compounds, pharmaceuticals, and personal 15 
care products (EDC/PPCPs) as important pollutants to remove from drinking water and reclaimed 16 
wastewater. In this work, the efficiency of removing pharmaceuticals (PCs) from model aqueous 17 
solutions and raw wastewater with ultrafiltration (UF), nanofiltration (NF), activated carbon 18 
adsorption (AC), biological methods (SBR) and oxidation with ClO2 was investigated. Some 19 
treatments have also been used as combined processes: UF+NF, UF+AC, SBR+ClO2. Ibuprofen, 20 
Acetaminophen, Diclofenac, Sulfamethoxazole, Clonazepam and Diazepam were selected as model 21 
compounds. In order to evaluate their removal, PC solutions were also considered at several 22 
operating conditions (pH, conductivity, concentration, temperature), and optimal conditions were 23 
obtained. Experiments were performed at usual PC concentrations in wastewaters: 1000 ng/L for 24 
Ibuprofen and Acetaminophen, 300 ng/L for Diclofenac, Sulfamethoxazole, Clonazepam, and 25 
Diazepam. Separation was evaluated by liquid chromatography-mass spectroscopy. Results 26 
indicated that the removal efficiency depends on their Log KOW, which is intrinsically related to 27 
their hydrophobicity and then, to their adsorption onto the surface (UF, NF and AC). Also, NF, AC 28 
and combined processes (UF+NF, UF+AC) were the most suitable separation techniques to obtain 29 
high removal efficiencies for most of the PCs used, except for Acetaminophen (which showed great 30 
removal efficacy using SBR). UF presented low removal yields for all PCs tested. ClO2 treatment 31 
was more effective at high concentration (50 mg ClO2/L). Furthermore, results also showed that 32 
there are significant differences on the performance of the processes applied and which treatment is 33 
the most effective for each PC analyzed. 34 
 35 
KEYWORDS: Pharmaceutical compounds, membrane processes, activated carbon, environmental 36 
analysis, hybrid process. 37 
 38 
1. INTRODUCTION 39 
The presence of pharmaceuticals and personal care products (PPCPs) in the environment is 40 
recognized as emerging issue due to their negative environmental and human health effects [1]. 41 
Pharmaceuticals (PCs) are introduced into the environment from discharges of wastewater 42 
treatment plants (WWTPs), which are not designed to treat all these substances and thus, they 43 
cannot be completely removed [2]. In this way, these effluents from WWTPs are relevant pollutant 44 
sources for the environment. Although PCs are present at very low concentrations (µg/L to ng/L 45 
range), they may cause environmental and health hazards [3]. Antimicrobial agents are the most 46 
widely used. As a major consequence, this usage could generate antibiotic-resistant bacteria, 47 
especially in quinolones and sulphonamides [4]. 48 
 49 
Furthermore, the application of sewage sludge to soils may be a potential route for these PCs to 50 
reach the terrestrial environment and then, the human food chain. In that way, it is not surprising 51 
that these antibiotics were detected even at subinhibitory concentrations in surface and 52 
groundwaters, treated wastewater, biosolids, soils, and sediments [5]. Removal efficiency for PCs at 53 
WWTPs depends on biological treatments [6], of which activated sludge process is the most 54 
frequently used. Although some promising technologies have been implemented, more studies are 55 
required to develop really effective treatments, especially for the most persistent chemicals.  56 
 57 
A combination between membrane filtration processes and biological treatment replaces 58 
advantageously a secondary clarification and tertiary steps. Ultrafiltration (UF) is used in 59 
wastewater treatment and drinking water production to remove natural organic matter (NOM) and 60 
micropollutants, such as pesticides and PCs [7,8]. In addition, these previous studies investigated 61 
different separation mechanisms (size/steric exclusion, hydrophobic adsorption, and electrostatic 62 
repulsion, among others). Recently, other membrane processes have been evaluated to remove PCs 63 
from wastewater. Nanofiltration (NF) has been used to successfully remove low-molecular-weight 64 
organic compounds such as pesticides, endocrine disruptors, and various PCs during water 65 
treatment [8-10]. This removal can occur through multiple mechanisms. At the beginning of the 66 
filtration process, removal can be governed by the adsorption phenomenon of different 67 
contaminants with hydrophobic nature or strong hydrogen-bonding characteristics [11-14]. 68 
Examples of this kind of contaminants are 2-naphthol, estrone, and non-phenolic pesticides. In 69 
many cases, removal can also occur through steady-state rejection. This may be due to steric effects 70 
for uncharged solutes or the combination of steric and electrostatic effects for charged solutes. 71 
These rejection mechanisms can affect different water-quality parameters including pH, ionic 72 
strength, and organic content [15].  73 
 74 
The removal of PCs by adsorption is one of the most promising techniques. Adsorption process 75 
using activated carbon (AC) is frequently applied for removing natural or synthetic organic 76 
compounds (OCs) in drinking water treatment [16]. This process has numerous advantages: 77 
applicability at very low concentrations of pollutants, ease of operation, suitable for batch and 78 
continuous processes, possibility of regeneration and reuse, and low capital cost [17]. AC is a useful 79 
adsorbent to remove PCs due to its high surface area, high degree of microporosity, and well-80 
developed surface chemistry properties. AC surface is predominantly hydrophobic but may also 81 
contain functional groups formed during the activation process. These groups mainly contain 82 
oxygen and hydrogen, but they may also contain chlorine, nitrogen, and sulphur. The nature of 83 
these functional groups depends on activation conditions, which contribute to the acidic/basic 84 
character of the adsorbent surface and thus, it has influence on specific interactions with adsorbed 85 
compounds [18]. It has been demonstrated that the presence of oxygen-containing functional groups 86 
on the surface and their concentration levels play an important role in adsorption capability and 87 
removal mechanism [19-21]. Other important AC properties are: pore size distribution [20,22], ash 88 
content [23], and pH of point of zero charge (pHPZC), as an indicator of AC surface chemistry [24]. 89 
AC can be produced from several carbonaceous materials, including wood, coal, lignin, and 90 
coconut shells [25]. Recent studies have reported excellent performance of low cost ACs for the 91 
removal of pharmaceutical compounds, which is an attractive and economic alternative for water 92 
treatment along with waste disposal and recycling [24]. AC can be commonly found in two 93 
different forms: powdered activated carbon (PAC) and granular activated carbon (GAC). Several 94 
authors demonstrated the efficiency of both ACs (PAC and GAC) in the removal of organic 95 
micropollutants from water [26,27]. Since PAC is dynamically added to the plant, it can be used 96 
seasonally to treat wastewater in which the risk of OCs traces could be great (e.g., low-flow events). 97 
The capability of PAC to remove OCs depends on the PAC dose and the contact time, as well as the 98 
target contaminant properties (e.g. water solubility, hydrophobicity, charge, polarizability, size, 99 
aromaticity and the presence of specific functional groups) [20,28]. GAC used in packed bed filters 100 
was also highly effective. However, more hydrophilic contaminants can break the GAC filter much 101 
more rapidly than strongly bound hydrophobic contaminants. Therefore, in both powdered and 102 
granular forms, AC demonstrates a great potential for removal OCs traces, although PAC dose and 103 
GAC regeneration/replacement are two critical parameters to be considered for obtaining a 104 
successful removal [28]. Generally, loaded GAC is regenerated ex situ by heating [29] or steaming 105 
[30]. After several regenerations, GAC is managed as a waste and is incinerated [31]. 106 
 107 
Other interesting technique to remove PCs is using a Sequencing Batch Reactor (SBR), which is 108 
based on the principles of the activated sludge process. In a SBR, oxygen is bubbled through the 109 
wastewater to reduce biochemical oxygen demand (BOD) and chemical oxygen demand (COD). 110 
After that, the effluent is suitable to be discharged to surface waters or to be used in agriculture. The 111 
operation cycle is divided into five phases: filling, aeration-reaction, settling, decantation and idle. 112 
SBR has been successfully employed in the treatment of both municipal and industrial wastewater 113 
[32]. Moreover, it has been demonstrated that SBR is valid as a system to remediate polycyclic 114 
aromatic hydrocarbons (PAH) contaminated sediments, while offering a high flexibility to adapt the 115 
process to the characteristics of the compounds to be treated. For instance, if the value of the 116 
volumetric exchange ratio could be properly controlled, it would be possible to limit the pollutant 117 
load of the biomass in the SBR. So, it could be avoided the inhibition phenomena [33]. 118 
 119 
Additional chemical oxidation step can be used in WWTPs if the pollutants are not completely 120 
removal by biological treatment [34,35]. Among the chemical oxidants used in wastewater 121 
treatment, chlorine dioxide (ClO2) is an interesting compound due to its potential to remove PCs in 122 
wastewater. The application of ClO2 to remove PCs from drinking water, surface water and 123 
wastewater effluents has shown promising results. The non-steroidal anti-inflammatory drug 124 
Diclofenac, reported as one of the most frequently detected compounds in water at concentrations 125 
up to the mg/L level [36], is completely degraded during water treatment with low ClO2 doses [37]. 126 
In wastewater effluents, steroid estrogens and industrial estrogenic chemicals were removed by 127 
using ClO2 doses between 1.25 and 3.75 mg/L. At the same time, the reduction of estrogenic 128 
potency was observed [38]. The capability of ClO2 as an oxidant has also demonstrated in the 129 
removal of several antibiotics found in water effluents [39,40]. When ClO2 was used in biologically 130 
treated wastewater for selective oxidation of organic micropollutants, it was found that smaller 131 
doses were rapidly consumed through reactions with soluble components in water. This fast 132 
consumption in wastewater was observed in previous studies by other authors [34,38,41]. Based on 133 
ClO2 reactivity in wastewater effluents, it has been suggested that ClO2 could be used as an 134 
alternative to ozone for the removal of micropollutants [42,43]. 135 
 136 
Taking into account all the information above mentioned, the aim of this work consists of 137 
evaluating the removal efficiency of some common PCs (Ibuprofen, Acetaminophen, Diclofenac, 138 
Diazepam, Clonazepam, and Sulfamethoxazole) from both model aqueous solutions and raw 139 
wastewaters. As a novelty, the performance of the most often used techniques for removal PCs (UF, 140 
NF, AC, SBR, and ClO2) were compared to the efficiency achieved by combining these techniques 141 
(AC+UF, UF+NF, SBR+ClO2). In addition, best techniques to remove each PC in terms of removal 142 
efficiency were suggested. 143 
 144 
2. MATERIALS AND METHODS 145 
 2.1. Pharmaceutical Compounds 146 
The choice of pharmaceutical compounds and their respective concentrations were performed 147 
according to their occurrence in the environment as explained above. The active principles and the 148 
main characteristics of the target PCs extracted from literature [8,28,44-46] can be observed in 149 
Table 1.  150 
 151 
The compounds selected were studied at the same concentration to simulate raw wastewater that 152 
was 1000 ng/L for Ibuprofen (Tarbis, Tarbis Farma, Spain) and Acetaminophen (Pensa, Pensa 153 
Pharma, Spain), and 300 ng/L for Diclofenac (Voltaren, Novartis Farmacéutica, Spain), 154 
Sulfamethoxazole (Septrin, UCB-Iberia, Spain), Clonazepam (Rivotril, Roche Farma, Spain) and 155 
Diazepam (Prodes, Kern Pharma, Spain).  156 
 157 
The pure active principles were obtained using the drugs from commercially available pad. The 158 
proportionality factor between the weight of the pad and the amount of active principle contained in 159 
it was calculated. PCs quantities are presented in Table 2. The effect of the remaining quantities of 160 
excipients (mainly cornstarch in small amounts) did not significantly influence on the experimental 161 
results [47]. 162 
 163 
 2.2. Membrane Processes 164 
 2.2.1. Ultrafiltration 165 
The first phase of the ultrafiltration experiment was focused on the determination of the 166 
permeability coefficient. The membrane used is an IRIS one (Orelis, France), made of 167 
polyethersulfone (PES), with a molecular weight cut-off (MWCO) of 3 kDa and an effective area of 168 
90.28 cm2. This membrane has similar MWCO range that those used for treating PCs by other 169 
researchers [8]. Characterization experiment of UF membrane involves the determination of the 170 
coefficient of permeability with deionized water at different transmembrane pressures (from 0.5 to 4 171 
bar). After the experiments, this coefficient had a value of 55 L/m2·h·bar.  172 
 173 
Experiments were carried out with two different simulate wastewaters. Wastewater Type I consisted 174 
of different solutions of each pharmaceutical compound in deionized water, whereas wastewater 175 
Type II is similar to Type I but adding bovine serum albumin (BSA) in its composition. According 176 
to Liang et al., this second model wastewater simulates a real wastewater from WWTP [48]. UF 177 
experimental set up was described previously in detail in a previous paper [49]. Permeate flux and 178 
rejection index were determined under the following operating conditions: temperature of 20 ºC, 179 
feed flow rate of 50 L/h (cross-flow velocity of 0.3 m/s) and transmembrane pressure (TMP) of 1.5 180 
bar. Flux and rejection measurements were performed after 1 hour (steady state conditions). 181 
 182 












E                 Eq. (1) 184 
where Cin was the concentration upstream of the treatment and Cout was the concentration 185 
downstream of the treatment. 186 
 187 
 2.2.2 Nanofiltration 188 
NF tests were performed in a pilot plant with a spiral wound composite polyamide membrane 189 
"Hydranautics ESNA1-LF2-2540" (Nitto-Denko, Switzerland). The experimental setup where these 190 
tests were carried out was adapted to NF and was described elsewhere [50]. The characterization of 191 
this NF membrane with deionized water showed a permeability coefficient of 4 L/m²·h·bar.  192 
 193 
NF experiments were carried out at a temperature of 16.5 ºC, feed flow rate of 370 L/h and a TPM 194 
of 15 bar, with a Type I feed. In addition, pH was modified in order to study its effect on the 195 
removal efficiencies. Permeate flux and rejection index of each compound were determined after 30 196 
minutes of filtration time. In a second stage, wastewater from a secondary treatment of a municipal 197 
wastewater treatment plant (MWWTP) with pharmaceutical compounds (Type III) was used as a 198 
feed solution. 199 
 200 
After each membrane separation procedure (both UF and NF), membranes were cleaned using 201 
chemical processes (alkaline solutions at pH = 10 and citric acid at pH = 3) and deionized water. In 202 
this way, membrane permeabilities were re-evaluated in order to restore the initial values of 203 
permeability. Also, both UF and NF experiments were repeated three times and the average was 204 
used to evaluate the performance of these membrane processes.  205 
 206 
  2.3. Activated Carbon 207 
Activated carbon was evaluated for removal of target PCs in wastewater Type II. Two 208 
commercially available AC were evaluated: Clarimex 061 CAE and Epibon YM 12X40, both 209 
provided by Chiemivall, Spain. Experiments were performed in a Jar test (Selecta) and the average 210 
of three samples obtained for each test was used to evaluate the process performance. The doses and 211 
contact times were based on full-scale treatment plants that frequently use AC. Therefore, a contact 212 
time of 4 h followed by 60 h of settling and AC doses of 10 and 50 mg/L were evaluated. 213 
Supernatant was collected and filtered to remove residual AC.  214 
 215 
 2.4. Oxidation with chlorine dioxide 216 
Chlorine dioxide solutions with a concentration of 3000 mg/L were prepared by sequentially mixing 217 
TwinOxide® reagents A (sodium chlorite) and B (sodium bisulphate) as it was indicated by the 218 
manufacturer (Brenntag Iberia, Spain). To study the PCs oxidation, different chloride dioxide 219 
concentrations (from 0 to 20 mg/L) from these solutions were mixed with samples of 400 mL of 220 
each PCs solution (Type I). The mixed solutions were allowed to react in the dark for 17 h at 221 
controlled temperature (22 ºC). After the reaction was complete, three samples of 250 ml of were 222 
taken from each reaction to be analyzed. 223 
 224 
 2.5. Sequencing Batch Reactor 225 
These experiments were performed in a SBR with a total volume of 10 L.. The reaction volume 226 
used was 6 L. It was equipped with an air pump and an air diffuser to keep dissolved oxygen (DO) 227 
above 3 mg/L, and a stirrer for mixing. Feeding and decanting were performed using two peristaltic 228 
pumps. Reactor feed was a solution prepared with 4.5 g of peptone (Cultimed, Panreac Spain), 4.5 g 229 
of meat extract (Cultimed, Panreac Spain) and 0.6 g of phosphor dissolved in tap water (Type IV). 230 
The cycle period was divided into five phases: filling (0.5 h), aeration-reaction (6 h), settling (1 h), 231 
decanting (0.25 h) and idle (0.25 h). The hydraulic retention time (HRT) for SBR experiments was 232 
16 h. The cycle was repeated 18 times to allow cell acclimation and/or to obtain repetitive results. 233 
Daily analysis of pH (Crison GLP 21+), conductivity (Crison GLP 31+), turbidity (Dinko 234 
turbidimeter d-112) and COD (kits from Merck Spain) of the supernatant were carried out. The 235 
effect of the ClO2 solutions during the SBR experiments was also tested as a combined process to 236 
be compared with SBR results. Concentration of mixed liquor suspended solids (MLSS) and mixed 237 
liquor volatile suspended solids (MLVSS) were measured throughout the operation according to 238 
standard methods [51]. 239 
 240 
The initial MLSS concentration was 2.5 g/L. After one week of feeding only with the above 241 
described simulated wastewater, pharmaceutical compounds were added to the feed solution once 242 
biomass was acclimated to the simulated wastewater. 243 
 244 
 2.6. Analytical method for PCs analysis 245 
 2.6.1. SPE for extraction of water samples 246 
The process SPE/clean-up used for water samples was based on that reported by Petrovic et al. [52]. 247 
PCs were isolated from water samples (250 ml, pH neutral) using an Oasis HLB cartridge [poly 248 
(divinylbenzene-co-N-pyrrolidone)] preconditioned with 5 mL of methanol and 5 mL of Milli-Q 249 
water. Samples were passed through the cartridges at a flow rate of 10 ml/min and then cartridges 250 
were rinsed with 5 ml of Milli-Q water and dried under vacuum for 15 minutes. The analytes 251 
retained were eluted with 6 ml of methanol. The extract was evaporated under a gentle stream of 252 
nitrogen and reconstituted with 1 ml methanol/water (25:75, v/v), filtered using syringe poly 253 
(tetrafluoroethylene) (PTFE) filters (0.22 μm, Analisis Vinicos, Tomelloso, Spain) and injected into 254 
the HPLC-MS/MS for analysis. 255 
 256 
 2.6.2. LC-ESI-MS/MS 257 
An 1260 Infinity Ultra High-Performance Liquid Chromatograph (UHPLC) tandem with a 6410 258 
Triple Quad Mass Spectrophotometer (MS/MS) is used for separating and determining, both of 259 
them of Agilent Technologies (Santa Clara, CA, USA). The analytical column was Kinetex 1.7 µm 260 
XB-C18 (60 x 2.10 mm) from Phenomenex (Paris, France). PCs were determined in both positive 261 
and negative ionization modes. In positive ionization (PI), the mobile phase was eluent A (formic 262 
acid 0.1 % in methanol) and eluent B (formic acid 0.1 % in water) in a gradient programme that 263 
started at 20 % A for 0.1 min, increased linearly to 90 % A in 15 min, then increased to 98 % A in 264 
15 min, hold for 8 min, and returned to the initial conditions after 1 min followed by 11 min of 265 
equilibration time. Flow rate used in these measurements was 0.2 mL/min. In negative ionization 266 
(NI), the mobile phase was methanol with 5 mM ammonium formate as eluent A and ammonium 267 
formate 5 mM in water as eluent B, at a flow rate of 0.2 mL/min. A gradient programme was used 268 
as follows: 15 % of eluent A for 0.1 min, followed by a linear increase to 98 % in 5 min, held for 7 269 
min. The injection volume was 20 µL. Compounds optimization was carried out with Optimizer 270 
program by Agilent Technologies. This program looks for the best transitions and conditions (the 271 
selected ones are shown in Table 3). Optimizer was configured to search a fragmentor from 5 to 200 272 
V and this can search each 10 steps. Collision energy Optimizer should search from 10 to 150 V. NI 273 
searches preferably [M-H]- whereas PI mode [M+H]+,[M+NH4]+ and [M+Na]+ [53]. 274 
 275 
 2.6.3. Validation of the analytical method 276 
Linearity was studied using standard solutions and matrix matched calibrations by analysing in 277 
triplicate seven concentration levels, between 7.5 and 7500 ng/mL in the final extract, equivalent to 278 
0.030 and 30 μg/L. Matrix effects were studied by comparison of the slopes of both regression 279 
equations. Samples were spiked with the analytes at 0.5 μg/L for water under the conditions 280 
described above. The limit of detection (LOD) and the limit of quantification (LOQ) were 281 
calculated as the amount of the analyte with a signal-to-noise ratio (SN) of 3 and 10, respectively 282 
[54]. Method LODs are outlined in Table 4. 283 
 284 
3. RESULTS AND DISCUSSION  285 
 3.1. Results of UF process 286 
Table 5 shows the PCs rejection obtained during the UF tests carried out with two different 287 
simulated wastewaters (Types I and II). The value of each parameter listed in this table is an 288 
average of that obtained in three independent experiments. Results indicated low rejection values 289 
for all PCs tested using Type I feed wastewater, which are similar to those obtained by Acero et al. 290 
in UF experiments with a PES membrane of 5000 Da [55]. However, three PCs (Ibuprofen, 291 
Diclofenac and Diazepam) presented higher rejection values during UF than the other compounds 292 
tested. The behaviour showed by these PCs could be intimately related to their Log KOW (logarithm 293 
of the octanol-water partition coefficient), which indicates the hydrophobicity of an organic 294 
compound and it is often used to describe the sorption potential of PCs in the aquatic environment 295 
[56]. The PCs with high retention value during UF process have a Log KOW next to 3 (Diazepam) or 296 
even higher (Ibuprofen and Diclofenac), where these results are in accordance with those obtained 297 
by other researchers. Lopez-Fernandez et al. [57] demonstrated that the PC adsorption on the 298 
membrane surface (in their case, PVDF membrane) is related to the Log KOW value. When this 299 
value is low (< 2.6), PCs have low lipophilicity and high hydrophilicity which indicates that these 300 
PCs are not adsorbed on the membrane surface (generally unmodified PVDF and PES have 301 
hydrophobic character [58,59]). On the other hand, when PCs have high Log KOW (> 4.5), the 302 
opposite effect is observed, being these compounds adsorbed on membrane surfaces [57]. Also, 303 
Yoon et al. demonstrated for UF and NF experiments that PCs with high average retention 304 
percentage had a Log KOW value higher than 3, which indicates that retention for hydrophobic 305 
membranes is influenced by hydrophobic interaction (adsorption) [8]. So, based on the results 306 
obtained by these researchers, the PCs could be adsorbed on the membrane surface depending on 307 
their Log KOW value. Diclofenac presented the highest rejection value and then, the highest 308 
adsorption on the surface of the PES membrane used because this molecule has the highest Log 309 
KOW value among all the PCs tested. 310 
 311 
When Type II wastewater was used as feed solution (with BSA in its composition), slightly higher 312 
rejection values were obtained for Diazepam. However, a huge increase in rejection values was 313 
observed for Ibuprofen, Sulfamethoxazole and Diclofenac, where the latter presented the highest 314 
rejection values among all the PCs tested (42.2 %). Chon et al. performed similar UF experiments 315 
with Diclofenac and Sulfamethoxazole, obtaining similar rejection values [45]. The increase in PCs 316 
rejection values using wastewater Type II could be due to their adsorption onto the proteins, which 317 
may form aggregates with higher size than the dissolved protein in the solution [60]. Other 318 
researchers as Sharma et al. studied the BSA interaction with two different PCs (Diclofenac sodium 319 
and Cefotaxime sodium) and they observed that the binding affinity of both PCs with BSA was 320 
high in a range of temperatures between 10 and 35 ºC. They also demonstrated that a tighter binding 321 
BSA and Diclofenac occurred [61]. In addition, Karpii et al. corroborated that the presence of 322 
albumin in serum diminished the adsorption of PCs onto a PVDF modified membrane [46].  323 
 324 
 3.2. Results of NF process 325 
NF reached high PCs removal efficiencies (between 60 and 92 %) with the exception of 326 
Acetaminophen (~2 %) as it is shown in Table 5. These results for this compound could be due to 327 
its low Log KOW value (0.46), as it was explained in section 3.1, its low molecular weight (151.2 328 
g/mol) and its neutral charge [57]. The difference between the Acetaminophen removal and the 329 
other PCs was higher in NF because the electrostatic repulsion forces between the membrane 330 
(polyamide) and the PC exerted more influence on membrane separation than in UF processes 331 
during the removal of the rest of PCs. Unlike some results reported by other authors [55], PCs 332 
removal efficiencies obtained in this work are slightly higher, due to the low MWCO of the 333 
membrane used (between 70 and 80 % of sodium chloride rejection under standard solutions 334 
according to the membrane supplier). 335 
 336 
The influence of pH solution on the PCs removal was considerable, especially in the case of 337 
Clonazepam, because the reduction of pH from 8.5 to 6.5 led to an increase in its removal efficiency 338 
from 22 to 80 % (see Table 5). Other researchers studied the pH influence on the rejection of PCs as 339 
one of the most important parameters that could affect the performance of UF, NF and RO 340 
membranes [45], Among all the PCs studied, the removal of Clonazepam is heavily influenced by 341 
changing the pH of the aquatic environment. The results for this compound reveal that the removal 342 
efficiency slightly decreased between pH values of 6.11 (80.33 %) and 6.48 (74.54 %). However, 343 
this removal efficiency vastly declined to 24.81 % at a pH value of 8.5. According to the pKa 344 
values for Clonazepam (1.5 y 10.5) presented in Table 1, this compound is protonated at highly 345 
acidic conditions and it becomes non-protonated (neutral) when pH values increases up to 6, as was 346 
demonstrated in separated studies by Miri and Jalali[62] and García and Perillo[63]. But, at alkaline 347 
conditions, the compound changes to its enolic form, which has enhanced its affinity to water due to 348 
the presence of charge on the molecule [62, 63]. This increase in water affinity leads to a lower 349 
retention of the PC molecule onto the membrane surface and therefore, its removal efficiency 350 
decreases.  351 
 352 
Results of the tests performed with Type II wastewater and with secondary effluent plus PCs (Type 353 
III) are also presented in Table 5. It can be observed that NF was still slightly more effective than in 354 
the case of Type I water (80-90 % of retention indexes). This behaviour could be explained by the 355 
interaction between PCs and organic compounds remaining in the secondary effluent, mainly 356 
proteins and carbohydrates coming from the release of cellular material. Acetaminophen was also 357 
the PC with the minimum rejection, though values were considerable higher than in the tests with 358 
synthetic solutions (55.34 %). 359 
 360 
 3.3. Results of the activated carbon tests 361 
In this section, results of the experiments with activated carbon using the source water Type II, with 362 
and without previous UF, are reported. 363 
 364 
 3.3.1. Activated Carbon 365 
Table 6 shows the removal efficiency for all PCs using AC. Great removal efficiencies were 366 
obtained for both ACs, especially at high AC concentration (50 mg/L). Thus, the increase of the 367 
concentration of both activated carbons coincided with an increase in their removal efficiency, with 368 
the only exception of Diclofenac (82.7 %  70.2 %) in the case of the use of Epibon (pulverized 369 
granular activated carbon). This result could be associated with the hydrophobic character of 370 
Diclofenac (high Log KOW) and the competitive inhibition of BSA with Diclofenac onto the 371 
activated carbon [64]. Only Acetaminophen had poor removal efficiency with Epibon 10 mg/L 372 
(only 12.9 %). According to Delgado et al., Log KOW could be a reasonable indicator of PCs 373 
removal when adsorption was only caused by hydrophobic interactions [65]. However, it cannot be 374 
considered an appropriate indicator for the adsorption of several compounds, for example for whose 375 
that contain heterocyclic or aromatic nitrogen, where electrostatic interactions, chemical bounding 376 
and non specific forces between the adsorptive and the AC surface are omitted through an exclusive 377 
Log KOW approach.. In addition, the removal efficiency was mostly dependent on the volume of the 378 
largest micropores of AC, because the solvation effect may enlarge the solute molecular dimensions 379 
thus hindering its access and packing in the narrower micropores. Moreover, Ji et al. observed that 380 
the adsorption of many antibiotics probably referred to a prominent size-exclusion effect when 381 
these compounds were adsorbed onto microporous ACs, because the porous structure of 382 
commercial ACs principally consisted of micropores with irregular-shaped and modestly closed 383 
pore structures [16].  384 
 385 
 3.3.2. Activated Carbon/Ultrafiltration combined process 386 
AC-UF system, which combines AC adsorption with low-pressure driven membrane filtration, 387 
showed great potential to adsorb pharmaceutical compounds (80-95 %), as it is displayed in Table 388 
6. All views expressed previously on activated carbon remain valid, showing this technique high 389 
efficiency in all the samples analysed. It was also observed that a combined process AC+UF 390 
improves the results obtained with AC treatments, especially at low AC concentrations. For 391 
Acetaminophen, these two technologies combined in series had low removal efficiency (~28-44 % 392 
with 10 mg/L and ~53-58 % with 50 mg/L) as already seen from the results separately obtained for 393 
UF and AC tests. 394 
 395 
 3.4. Chlorine dioxide results 396 
Among the six investigated compounds, only Diazepam showed an appreciable reactivity, as it is 397 
seen in Figure 1. Results obtained for Diazepam showed that an increase in ClO2 concentration 398 
coincided with an increase in the removal efficiency, achieving values of 66 %. Therefore, it could 399 
be concluded that ClO2 applied in water treatment only acted as a partial barrier for PCs, even 400 
though it is relatively effective in oxidizing antibiotics and estrogens. These two compounds merit 401 
special concern due to their high biological activity. This is in accordance with the results reported 402 
by Huber et al., even though results are not fully comparable, because they investigated three 403 
different water sources (drinking water, lake water, groundwater) and used different experimental 404 
conditions: lower ClO2 concentrations, variable time reaction, and higher compounds concentration 405 
(~µg) [37]. However, they obtained good removal values for Sulfamethoxazole and Diclofenac, 406 
justifying according to the reactivity of the aniline group (contained in both compounds) to ClO2 407 
and because the deprotonation of acidic nitrogen of the sulfonamide moiety enhanced the reactivity 408 
of Sulfamethoxazole. Hey et al. investigated several compounds, but they do not study Diazepam 409 
and they also used higher concentrations (100 mg). The poor efficiency of this treatment could be 410 
due to the lower concentration used and the dependence of the degree of oxidation on the type of 411 
wastewater. Furthermore, reactivity of the compounds depended on the reactive functional group 412 
present [66]. 413 
 414 
 3.5. SBR results 415 
This type of treatment had different results depending on the pharmaceutical component analysed. 416 
SBR results without and with ClO2 in terms of removal efficiency were presented in Table 7. Good 417 
results for Ibuprofen and Acetaminophen (∼90-95 % for both compounds) were observed, whereas 418 
scarce removal efficiencies were shown for Diclofenac (∼25 %), Sulfamethoxazole (∼20 %), and 419 
Diazepam (∼15 %). Regarding the Clonazepam, removal efficiency presented very acceptable 420 
results (∼85 %). During the operation time of all of these processes, MLSS, MLVSS, pH, 421 
conductivity, turbidity and COD were also measured and their results are shown in Table 8. Before 422 
the addition of ClO2, the different parameters measured during SBR tests did not change 423 
significantly. After the addition of ClO2 to SBR, an initial decrease in biomass parameters as well as 424 
an increase in conductivity was detected. In the same way, the presence of ClO2 led to a general 425 
increase in the removal efficiency in the first days of treatment. There are no similar data present in 426 
literature, in fact Elmolla and Chaudhuri investigated different PCs (Amoxicillin and Cloxacillin), 427 
at different working conditions (1.5 L in volume and a biomass concentration of 2300 mg/L) and 428 
with Fenton pre-treatment system. They defined the best operating conditions for treatment of the 429 
antibiotic wastewater by combined Fenton-SBR process, which were H2O2/COD molar ratio 2.5, 430 
H2O2/Fe2+ molar ratio 150, Fenton reaction time 120 min and a HRT of 12 h. Under these 431 
conditions, they obtained a removal efficiency of 89 % for COD removal and the SBR effluent met 432 
the discharge standards [67]. 433 
 434 
 3.6. Results for single compound 435 
This section has the aim of summarizing all the results obtained for each PC studied, which are 436 
displayed in Tables 5-7. In this way, it will be clear which processes may be the most effective for 437 
their separation. 438 
 439 
Ibuprofen had very poor percentages of removal with UF treatments (36.33 %), but excellent 440 
removals when UF is combined with NF (≥ 99 %). These results are higher than those obtained 441 
using only NF (75-90 %). Excellent results were also obtained with AC treatments at high AC 442 
concentration (≥ 95 %), and with SBR during the first days of the cycle (≥ 95 %). 443 
 444 
Acetaminophen had generally low removal efficiencies using NF experiments at different pHs (≤ 13 445 
%). These results could be attributed to its low molecular weight and its low value of Log KOW 446 
(values displayed in Table 1), as it was explained in sections 3.1 and 3.2. UF processes were also 447 
ineffective (~1.6 %), in contrast to SBR results, which presented high percentages of removal (≤ 95 448 
%). 449 
 450 
For Diclofenac, AC+UF had excellent removal efficiencies (≥ 95 %), which were better than those 451 
obtained when both processes were individually implemented (≥ 68 % for AC and 42.2 % for UF). 452 
The same trend is observed for the combination of UF+NF, which gave excellent results (≥ 98 %). 453 
SBR processes (with and without ClO2) had very low removal efficiencies (~10-38 %). 454 
 455 
The AC treatments applied for removal Sulfamethoxazole had good removal efficiencies, especially 456 
excellent results were obtained at high AC concentrations (≥92 %). These results improved when 457 
AC was combined with a UF process (~96-99 % with 50 mg/L). UF treatments had poor efficiency 458 
(~10-21 %), while NF processes presented excellent results (~70-98 %). Regarding the results for 459 
SBR processes (with and without ClO2), very low removal efficiencies (~19-40 %) were obtained. 460 
 461 
For the benzodiazepines studied, Clonazepam had excellent removal efficiencies during NF 462 
treatment of real wastewater (≥ 90 %) and at pH next to 6 (≥ 74 %), but these values decreased to 463 
25 % at pH = 8.5 when this compound changed to a enolic form (as it was indicated in section 3.2). 464 
Regarding the SBR results, they suggested an increase in the efficiency of removal during the 465 
course of the days (~70-85 %), but in the case of introduction of ClO2 the long-term interaction with 466 
the biomass decreased and consequently the effectiveness of removal (41.5 %). In the case of 467 
Diazepam, it had excellent removal percentages when was treated using NF process (≥ 88 %), AC 468 
treatment at low concentrations (≥ 93 %), but poor efficiencies with UF (~19 %). Among all the 469 
PCs tested, this compound is the only one that showed an increase in the removal efficiency using 470 
ClO2, which increased when ClO2 concentration was higher. Finally, poor results were obtained 471 
with SBR processes (~15 % without ClO2 and ~39 % with ClO2).  472 
 473 
4. CONCLUSIONS 474 
The removal efficiency of six different pharmaceuticals using several separation techniques was 475 
studied to determine the most appropriate method for each pharmaceutical. In the case of membrane 476 
processes, UF was practically ineffective for all the compounds tested, obtaining the best removal 477 
efficiencies for all compounds using NF process, except for Acetaminophen and Ibuprofen. Both 478 
compounds presented the highest removal percentages with SBR, but this treatment had lower 479 
removal efficiencies for the remaining pharmaceuticals, for which NF process was better. As 480 
regards the AC tests, these experiments had excellent removal efficiency for almost all the 481 
pharmaceuticals examined (especially at high AC concentration, 50 mg/L), except for 482 
Acetaminophen. Therefore, Acetaminophen is the pharmaceutical compound with most difficulties 483 
to be treated, due to the low effect of the treatments used along this study. In addition, Diazepam is 484 
the only compound that showed an increase of the removal efficiency with ClO2. Also, an increase 485 
in ClO2 concentration gradually led to a better removal results. Finally, the combined UF+NF 486 
process was the most effective of all the treatments performed. 487 
 488 
For all pharmaceuticals, a general trend appeared with higher mass recovery at high Log KOW. 489 
Although experimental and analytical accuracy could vary the mass recovery, these results 490 
indicated that observed retention for the relatively hydrophobic compounds based on their Log KOW 491 
was significantly governed by adsorption. 492 
 493 
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Log Kow pKa Ref. 
Ibuprofen 
 
206.29 3.97 4.91 [44] 
Acetaminophen 
 
151.2 0.46 9.4 [8] 
Diclofenac 
 
296.14 4.51 4.15 [45] 
Sulfamethoxazole 
 
253.28 0.89 5.5 [28] 
Clonazepam 
 
315.71 2.41 10.5 (1-position) 1.5 (4-position) [46] 
Diazepam 
 
284.80 2.82 3.3 [8] 
 
Table 2. Active principle and quantities of the pharmaceuticals used. 
Pharmaceutical names Active principle Weight a single pad (mg) 
Weight active principle 
for pad (mg) 
Proportional 
parameter 
Tarbis Ibuprofen 771.3 600 1.2855 
Acetaminophen Pensa Acetaminophen 1308.4 1000 1.3084 
Voltaren Diclofenac 210.9 50 4.218 
Septrin Sulfamethoxazole 501.6 400 1.254 
Rivotril Clonazepam 153.8 0.5 307.6 
Diazepan Prodes Diazapem 77.7 2.5 31.08 
Table 3. Experimental parameters of the analytical method used. 











PI Mode       
Diazepam 156 285 →193 34 156 285 →154 26 
Clonazepam 136 316 →270 24 136 316→214 35 
Acetaminophen 112 152 → 110 13 112 152 → 65 33 
Sulfamethoxazole 104 254 → 156 10 104 254 → 92 26 
NI Mode       
Ibuprofen 68 205 → 161 2  - - 
Diclofenac 88 294 → 249 10 88 294 → 178 22 
 
Table 4. Limit of detection values (LOD) for all the compounds tested. 
Compound LOD 
Ibuprofen 6.8 ng/L 
Diazepam 0.3 ng/L 
Clonazepam 0.5 ng/L 
Acetaminophen 0,9 ng/L 
Diclofenac 2,5 ng/L 
Sulfamethoxazole 0,9 ng/L 
 
Table 5. Removal efficiencies (%) for each selected pharmaceutical compound using different membrane 
separation processes and wastewaters (Type I, II and III). 
Pharmaceutical 
compound 
UF NF UF + NF 




(pH=8.5) Type III Type II 
Ibuprofen 12.21 26.33 80.51 86.57 91.38 87.18 95.18 
Diazepam 18.98 19.14 87.41 90.96 91.28 91.37 99.69 
Acetaminophen Non detected 1.60 1.62 4.91 12.60 55.34 76.50 
Sulfamethoxazole 10.70 20.80 --- 70.78 --- 98.21 99.90 
Clonazepam --- --- 80.33 74.54 24.81 90.32 --- 
Diclofenac 24.70 42.20 66.91 68.69 76.45 82.99 98.14 
 
Table 6. Removal efficiencies (%) for each selected pharmaceutical compound using two different 





















Ibuprofen 43.02 99.00 77.20 95.35 63.72 99.90 85.48 97.04 
Diazepam 94.59 97.04 93.66 97.02 95.63 97.61 94.88 97.60 
Acetaminophen 32.10 43.00 12.90 48.60 44.00 53.00 28.20 57.60 
Sulfamethoxazole 54.00 92.30 71.90 94.20 67.90 94.60 80.40 96.00 













SBR SBR + ClO2 
4th day 8th day 1st day 4th day 8th day 
Ibuprofen 89.40 94.59 90.35 96.08 93.74 
Diazepam 2.78 15.22 39.27 30.11 13.95 
Acetaminophen 94.19 90.55 97.46 95.79 54.40 
Sulfamethoxazole 19.21 20.33 29.91 40.54 25.64 
Clonazepam 52.54 84.93 71.87 72.11 41.50 
Diclofenac 10.29 25.93 10.58 37.56 25.96 
 
Table 8. SBR experimental results. 











1 1.175 0.993 84.511 - - - - 
2 1.098 0.960 87.432 7.30 1070 10.70 - 
3 1.999 1.775 88.794 7.16 1035 - - 
4 2.311 2.009 86.932 7.05 1017 - - 
7 (pharma) 2.784 2.376 85.345 7.18 1032 2.02 16.90 
8 2.876 2.558 88.943 7.18 1045 - - 
9 2.833 2.495 88.069 7.73 1064 - - 
10 (after purge) 2.408 2.208 91.694 7.12 1042 - - 
11 2.763 2.514 90.988 7.55 1062 - - 
14 (ClO2) 2.758 2.562 92.893 7.57 1009 2.58 18 
15 2.754 2.478 89.978 7.45 1053 - - 
16 2.539 2.277 89.681 7.70 1141 - - 
17 2.333 2.120 90.870 7.69 1133 - - 
18 (after purge) 2.518 2.258 89.674 7.60 1134 - - 





Figure 1. Removal efficiencies (%) of Diazepam at different ClO2 concentrations. 
 
